Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
5,053 total articles
Christian LaPointe, General Counsel and Corporate Secretary of Quantum-Si Inc (NASDAQ: QSI), disposed of 11,959 shares across two transactions on March 20 and March 23, 2026, generating roughly $10,012. The sales were made under a required sell-to-cover arrangement to satisfy withholding tax on vested restricted stock units. The trades come as QSI …
Jeffrey Alan Hawkins, President and CEO of Quantum-Si Inc (NASDAQ: QSI), completed two sell-to-cover transactions on March 20 and March 23, 2026, disposing of 23,777 Class A shares for a combined $19,906, according to a Form 4 filing. The sales were conducted to cover tax obligations from the vesting of restricted stock units. The filings also show…
Ashoo Gupta, vice president of finance and controller at 4D Molecular Therapeutics, sold 390 shares of common stock for $3,357 on March 20, 2026, while also converting restricted stock units into additional shares. The transactions occur as the company draws analyst focus for its retinal disease clinical programs and as its share price has risen sh…
Teresa L. Dick, chief administrative officer and executive vice president of Diamondback Energy Inc. (NASDAQ: FANG), sold 5,000 shares on March 20, 2026, for $193.00 per share, a transaction valued at $965,000. The sale occurred while the stock was trading close to its 52-week peak and following a quarter in which the company delivered stronger-tha…
Diamondback Energy Executive Vice President and COO Daniel N. Wesson sold 5,000 shares on March 20, 2026, for roughly $959,776. The transaction was filed on a Form 4 with the SEC. The sale comes amid strong fourth-quarter 2025 production results, analyst price target increases, and a substantial secondary share offering that will not benefit the co…
Pharmacy Investors, LLC disclosed the sale of 827,636 Class A shares of Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) on March 20, 2026, in a Form 4 filing with the SEC. The shares were sold at $29.6825 each for a total of $24,566,305. The sale followed an underwriting agreement dated March 18, 2026. Since the sale, GRDN has risen to $37.57, trad…
Exzeo Group Chief Executive Officer Paresh Patel acquired 2,000 shares of company common stock at $14.99 per share on March 24, 2026, for a total of $29,980. The purchase comes while the shares have fallen 39% year-to-date and are trading at $14.81; Exzeo reported fourth-quarter and full-year 2025 results that matched analysts' forecasts, with dilu…
Guardian Pharmacy Services CFO David K. Morris sold 187,855 Class A shares on March 20, 2026, for roughly $5.576 million under an underwriting agreement dated March 18, 2026. The shares have since risen to $37.57, near their 52-week high, while analysts lifted price targets after the company's solid fourth-quarter results. A recent underwritten off…
Hims & Hers Health CFO Oluyemi Okupe sold 9,217 shares of Class A stock on March 20, 2026, generating about $219,066, and exercised options to acquire 4,489 shares. The transactions, carried out under a Rule 10b5-1 plan, follow the company’s partnership with Novo Nordisk and recent corporate developments that have driven a sharp share-price rally.
Marcus Corporation President Michael Reade Evans sold a small block of company shares on March 20, 2026, while the company reported a fourth-quarter fiscal 2025 earnings-per-share beat alongside a slight revenue shortfall. Evans retains a substantial direct stake and holds a portfolio of stock options that vest over time. Analysts remain constructi…
Viatris Inc. Chief Accounting Officer and Corporate Controller Paul Campbell sold 21,350 shares on March 23, 2026, generating proceeds of $283,538 at a weighted average price of $13.2805. The transaction comes amid the company's forward financial guidance to 2030, recent regulatory approval in Japan, and a series of analyst price-target revisions. …
Daxor Corp's Chief Medical Officer, John Jefferies, reported two acquisitions totaling 5,941 shares of common stock on March 20, 2026. The filings list the transactions at a $0 price per share. The moves come as the stock trades at $10.34, while the company has reported strong operating revenue growth, increased net assets and completed a registere…
Vishal Garg, Chief Executive Officer of Better Home & Finance Holding Co (BETR), purchased Class A Common Stock across several transactions on March 23 and March 24, 2026, totaling $618931. The buys were executed at prices between $28.3743 and $30.0603 and bring Garg's direct ownership to 52660 shares. The activity coincides with the company’s repo…
AtaiBeckley Inc.'s Chief Medical Officer, Craig Kevin James, sold 100,000 shares of common stock on March 20, 2026, at $3.55 per share, generating $355,000. On the same date he exercised options to acquire 100,000 shares in two tranches. The company has seen notable index inclusions and released Phase 2a results for its nasal spray candidate BPL-00…
Neuronetics Executive Vice President and CFO Steven Pfanstiel sold 16,431 shares on March 19, 2026 to meet tax obligations tied to performance-restricted stock units. The transaction, executed between $1.20 and $1.48 per share for roughly $22,017, leaves Pfanstiel with 828,781 shares. The stock trades near its fair value amid recent price volatilit…
Diana Sroka, a director at SoundHound AI, sold 1,343 shares of Class A common stock on March 23, 2026, under a Rule 10b5-1 plan. The shares fetched between $6.66 and $6.91 apiece for proceeds of roughly $9,093. SoundHound reported fiscal Q4 2025 revenue above estimates, saw an analyst reiterate a Buy rating, and disclosed its CFO will depart in ear…
ServisFirst Bancshares director J. Richard Cashio sold 42,000 shares on March 24, 2026, generating $3.1 million in proceeds. The transaction comes after the company reported fourth-quarter 2025 results that exceeded estimates and an upgrade from Raymond James. Cashio retains a substantial direct and indirect holding in the bank.
SoundHound AI Chief Technology Officer Timothy Stonehocker sold 23,087 shares of Class A Common Stock on March 20, 2026, for about $156,767, at $6.7903 per share. The sale, disclosed in a Form 4 filed March 24, 2026, satisfied tax-withholding obligations tied to the vesting of restricted stock units granted across 2022, 2023 and 2024. The stock is …
SoundHound AI Chief Operating Officer Michael Zagorsek sold 52,968 shares of Class A Common Stock on March 20, 2026, to satisfy tax withholding related to restricted stock units. The shares fetched $6.79 each for a total of $359,668. The stock has since traded lower, near its 52-week low. The company reported fiscal Q4 2025 revenue above expectatio…
Keith J. Sullivan, a former officer and director at Neuronetics, sold 46,289 shares on March 19, 2026 to satisfy a tax withholding obligation tied to the vesting of a performance restricted stock unit award. The disposals, executed at prices between $1.20 and $1.48 per share for roughly $62,027, leave Sullivan with a direct stake of 1,590,924 share…
AST SpaceMobile Inc. Chief Technology Officer Yao Huiwen executed sales of 40,000 Class A shares on March 23, 2026, generating $3,555,200 at a weighted average price of $88.88 under a Rule 10b5-1 trading plan adopted in June 2025. The company reported fourth-quarter 2025 revenue ahead of expectations but missed on EPS, and announced a commercial ag…
SoundHound AI CFO Nitesh Sharan sold 44,027 shares of Class A common stock on March 20, 2026, for roughly $298,956 to satisfy tax withholding tied to vested restricted stock units. The sale occurred as the stock traded near its 52-week low and follows a fiscal-quarter revenue beat and an announced CFO departure effective April 3, 2026.
SoundHound AI Chief Executive Keyvan Mohajer sold 124,510 Class A shares on March 20, 2026, for $6.7903 each, generating $845,460. The transaction was executed to satisfy tax-withholding obligations tied to restricted stock unit vesting. The sale comes while the company's stock trades near its 52-week low and after a year of almost doubling revenue…
James Ming Hom, Chief Product Officer and co-founder of SoundHound AI, sold 31,019 shares of Class A common stock on March 20, 2026 to meet tax withholding obligations tied to restricted stock unit vesting. The sale generated $210,628 at a per-share price of $6.7903. SoundHound reported fourth-quarter fiscal 2025 revenue of $55.1 million, topping a…
Neuronetics Executive Vice President, CLO and CS William Andrew Macan sold 16,005 shares of common stock on March 19, 2026, generating roughly $21,446. The disposition, disclosed on a Form 4 filing, was carried out at prices between $1.20 and $1.48 to satisfy tax withholding from vested performance restricted stock units. The company recently repor…
